Chemokines and chemokine receptors: Update on utility and challenges for the clinician

Surgery (United States)

Volumn 155, Issue 6, 2014, Pages 961-973

  Roy, Ishan ^a   Evans, Douglas B ^a   Dwinell, Michael B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCL1 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; CXCL9 CHEMOKINE; EOTAXIN; EOTAXIN 2; EOTAXIN 3; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; MONOCYTE CHEMOTACTIC PROTEIN 5; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANGINA PECTORIS; ANGIOGENESIS; ATHEROSCLEROSIS; ATOPIC DERMATITIS; BREAST CANCER; CANCER GROWTH; CELL MIGRATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COLITIS; COLORECTAL CANCER; EMBRYO DEVELOPMENT; ESOPHAGUS CANCER; HEART INFARCTION; HEPATITIS C; HUMAN; IMMUNOCOMPETENT CELL; KIDNEY CANCER; LUNG CANCER; LUNG NON SMALL CELL CANCER; MELANOMA; MULTIPLE SCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOSARCOMA; OVARY CANCER; PANCREAS CANCER; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL (TOPIC); PHYSIOLOGY; PRIORITY JOURNAL; PSORIASIS; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; WOUND HEALING;

BIOLOGICAL MARKERS; CHEMOKINES; EMBRYONIC DEVELOPMENT; HUMANS; INFLAMMATION; MOLECULAR TARGETED THERAPY; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, CHEMOKINE; WOUND HEALING;

EID: 84901387582     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2014.02.006     Document Type: Review

References (116)

1. P.M. Murphy, M. Baggiolini, I.F. Charo, C.A. Hébert, R. Horuk, and K. Matsushima et al. International union of pharmacology. XXII. nomenclature for chemokine receptors Pharmacol Rev 52 2000 145 176
2. A. Zlotnik, and O. Yoshie Chemokines: a new classification system and their role in immunity Immunity 12 2000 121 127
3. A. Zlotnik Chemokines and cancer Int J Cancer 119 2006 2026 2029
4. A. Zlotnik, and O. Yoshie The chemokine superfamily revisited Immunity 36 2012 705 716
5. C.A. Hébert, R.V. Vitangcol, and J.B. Baker Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding J Biol Chem 266 1991 18989 18994
6. E.R. Neptune, and H.R. Bourne Receptors induce chemotaxis by releasing the βγ subunit of gi, not by activating gq or Gs Proc Natl Acad Sci U S A 94 1997 14489 14494
7. R.A. Moyer, M.K. Wendt, P.A. Johanesen, J.R. Turner, and M.B. Dwinell Rho activation regulates CXCL12 chemokine stimulated actin rearrangement and restitution in model intestinal epithelia Lab Invest 87 2007 807 817
8. L.J. Drury, M.K. Wendt, and M.B. Dwinell CXCL12 chemokine expression and secretion regulates colorectal carcinoma cell anoikis through bim-mediated intrinsic apoptosis PLoS One 5 2010 e12895
9. L.J. Drury, J.J. Ziarek, S. Gravel, C.T. Veldkamp, T. Takekoshi, and S.T. Hwang et al. Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways Proc Natl Acad Sci U S A 108 2011 17655 17660
10. K.A. Agle, R.A. Vongsa, and M.B. Dwinell Calcium mobilization triggered by the chemokine CXCL12 regulates migration in wounded intestinal epithelial monolayers J Biol Chem 285 2010 16066 16075
11. T. Murakami, A.R. Cardones, S.E. Finkelstein, N.P. Restifo, B.A. Klaunberg, and F.O. Nestle et al. Immune evasion by murine melanoma mediated through CC chemokine receptor-10 J Exp Med 198 2003 1337 1347
12. M. Wong, S. Uddin, B. Majchrzak, T. Huynh, A.E.I. Proudfoot, and L.C. Platanias et al. RANTES activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells J Biol Chem 276 2001 11427 11431
13. M. Mellado, J.M. Rodríguez-Frade, S. Mañes, and C. Martínez-A Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation Annu Rev Immunol 19 2001 397 421
14. J.A. Wojcechowskyj, J.Y. Lee, S.H. Seeholzer, and R.W. Doms Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling PLoS One 6 2011 e24918
15. B.J. Rollins Chemokines Blood 90 1997 909 928
16. J.G. Cyster Chemokines and cell migration in secondary lymphoid organs Science 286 1999 2098 2102
17. S. Paoletti, V. Petkovic, S. Sebastiani, M.G. Danelon, M. Uguccioni, and B.O. Gerber A rich chemokine environment strongly enhances leukocyte migration and activities Blood 105 2005 3405 3412
18. R. Förster, A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Müller, and E. Wolf et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs Cell 99 1999 23 33
19. S.N. Mueller, and R.N. Germain Stromal cell contributions to the homeostasis and functionality of the immune system Nat Rev Immunol 9 2009 618 629
20. J.N. Barker, V. Sarma, R.S. Mitra, V.M. Dixit, and B.J. Nickoloff Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors J Clin Invest 85 1990 605 608
21. N. Ogawa, L. Ping, L. Zhenjun, Y. Takada, and S. Sugai Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma- inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome Arthritis Rheum 46 2002 2730 2741
22. N.P. Zimmerman, R.A. Vongsa, M.K. Wendt, and M.B. Dwinell Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease Inflamm Bowel Dis 14 2008 1000 1011
23. A. Vecchi, L. Massimiliano, S. Ramponi, W. Luini, S. Bernasconi, and R. Bonecchi et al. Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells J Leukoc Biol 66 1999 489 494
24. T. Murakami, A.R. Cardones, and S.T. Hwang Chemokine receptors and melanoma metastasis J Dermatol Sci 36 2004 71 78
25. J.A. Belperio, M.P. Keane, D.A. Arenberg, C.L. Addison, J.E. Ehlert, and M.D. Burdick et al. CXC chemokines in angiogenesis J Leukoc Biol 68 2000 1 8
26. J. Heidemann, H. Ogawa, P. Rafiee, N. Lügering, C. Maaser, and W. Domschke et al. Mucosal angiogenesis regulation by CXCR4 and its ligand CXCL12 expressed by human intestinal microvascular endothelial cells Am J Physiol 286 2004 G1059 G1068
27. J. Heidemann, H. Ogawa, M.B. Dwinell, P. Rafiee, C. Maaser, and H.R. Gockel et al. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2 J Biol Chem 278 2003 8508 8515
28. R.M. Strieter, P.J. Polverini, S.L. Kunkel, D.A. Arenberg, M.D. Burdick, and J. Kasper et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis J Biol Chem 270 1995 27348 27357
29. C.L. Addison, T.O. Daniel, M.D. Burdick, H. Liu, J.E. Ehlert, and Y.Y. Xue et al. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity J Immunol 165 2000 5269 5277
30. R. Salcedo, and J.J. Oppenheim Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses Microcirculation 10 2003 359 370
31. V. Hannelien, G. Karel, V.D. Jo, and S. Sofie The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer Biochim Biophys Acta 1825 2012 117 129
32. K. Tachibana, S. Hirota, H. Iizasa, H. Yoshida, K. Kawabata, and Y. Kataoka et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract Nature 393 1998 591 594
33. K. Katsumoto, and S. Kume Endoderm and mesoderm reciprocal signaling mediated by CXCL12 and CXCR4 regulates the migration of angioblasts and establishes the pancreatic fate Development 138 2011 1947 1955
34. C. Dambly-Chaudiere, N. Cubedo, and A. Ghysen Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1 BMC Dev Biol 7 2007 23
35. G. Valentin, P. Haas, and D. Gilmour The chemokine SDF1a coordinates tissue migration through the spatially restricted activation of Cxcr7 and Cxcr4b Curr Biol 17 2007 1026 1031
36. A. Peled, I. Petit, O. Kollet, M. Magid, T. Ponomaryov, and T. Byk et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4 Science 283 1999 845 848
37. I. Voigt, S.A. Camacho, B.A. de Boer, M. Lipp, R. Förster, and C. Berek CXCR5-deficient mice develop functional germinal centers in the splenic T cell zone Eur J Immunol 30 2000 560 567
38. D.J. Ceradini, A.R. Kulkarni, M.J. Callaghan, O.M. Tepper, N. Bastidas, and M.E. Kleinman et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 Nat Med 10 2004 858 864
39. N.J. Hannan, and L.A. Salamonsen Role of chemokines in the endometrium and in embryo implantation Curr Opin Obstet Gynecol 19 2007 266 272
40. T. Nagasawa, S. Hirota, K. Tachibana, N. Takakura, S. Nishikawa, and Y. Kitamura et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 Nature 382 1996 635 638
41. Y. Zou, A.H. Kottmann, M. Kuroda, I. Taniuchi, and D.R. Littman Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development Nature 393 1998 595 599
42. N.J. Hannan, R.L. Jones, C.A. White, and L.A. Salamonsen The chemokines, CX3CL1, CCL14, and CCL4, promote human trophoblast migration at the feto-maternal interface Biol Reprod 74 2006 896 904
43. L.B. Nanney, S.G. Mueller, R. Bueno, S.C. Peiper, and A. Richmond Distributions of melanoma growth stimulatory activity of growth-regulated gene and the interleukin-8 receptor B in human wound repair Am J Pathol 147 1995 1248 1260
44. Y. Ishida, J. Gao, and P.M. Murphy Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function J Immunol 180 2008 569 579
45. D. Inokuma, R. Abe, Y. Fujita, M. Sasaki, A. Shibaki, and H. Nakamura et al. CTACK/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes Stem Cells 24 2006 2810 2816
46. M.B. Dwinell, P.A. Johanesen, and J.M. Smith Immunobiology of epithelial chemokines in the intestinal mucosa Surgery 133 2003 601 607
47. J.M. Smith, P.A. Johanesen, M.K. Wendt, D.G. Binion, and M.B. Dwinell CXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrity Am J Physiol 288 2005 G316 G326
48. R. Gillitzer, and M. Goebeler Chemokines in cutaneous wound healing J Leukoc Biol 69 2001 513 521
49. I. Dotan, L. Werner, S. Vigodman, S. Weiss, E. Brazowski, and N. Maharshak et al. CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system Inflamm Bowel Dis 16 2010 583 592
50. E.C. Butcher, and L.J. Picker Lymphocyte homing and homeostasis Science 272 1996 60 67
51. A. Peled, O. Kollet, T. Ponomaryov, I. Petit, S. Franitza, and V. Grabovsky et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34+ cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice Blood 95 2000 3289 3296
52. A.D. Luster Chemokines - chemotactic cytokines that mediate inflammation N Engl J Med 338 1998 436 445
53. P.V. Moghe, R.D. Nelson, and R.T. Tranquillo Cytokine-stimulated chemotaxis of human neutrophils in a 3-D conjoined fibrin gel assay J Immunol Methods 180 1995 193 211
54. C.T. Veldkamp, F.C. Peterson, A.J. Pelzek, and B.F. Volkman The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin Protein Sci 14 2005 1071 1081
55. M. Shirozu, T. Nakano, J. Inazawa, K. Tashiro, H. Tada, and T. Shinohara et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene Genomics 28 1995 495 500
56. M.K. Wendt, P.A. Johanesen, N. Kang-Decker, D.G. Binion, V. Shah, and M.B. Dwinell Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis Oncogene 25 2006 4986 4997
57. M. Tessema, D.M. Klinge, C.M. Yingling, K. Do, L. Van Neste, and S.A. Belinsky Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis Oncogene 29 2010 5159 5170
58. D. Baumhoer, J. Smida, S. Zillmer, M. Rosemann, M.J. Atkinson, and P.J. Nelson et al. Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma Mod Pathol 25 2012 522 528
59. M.K. Wendt, A.N. Cooper, and M.B. Dwinell Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells Oncogene 27 2008 1461 1471
60. M.K. Wendt, L.J. Drury, R.A. Vongsa, and M.B. Dwinell Constitutive CXCL12 expression induces anoikis in colorectal carcinoma cells Gastroenterology 135 2008 508 517
61. H. Sigmundsdottir, J. Pan, G.F. Debes, C. Alt, A. Habtezion, and D. Soler et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 Nat Immunol 8 2007 285 293
62. A. Facciabene, X. Peng, I.S. Hagemann, K. Balint, A. Barchetti, and L. Wang et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and treg cells Nature 475 2011 226 230
63. C. Maerki, S. Meuter, M. Liebi, K. Mühlemann, M.J. Frederick, and N. Yawalkar et al. Potent and broad-spectrum antimicrobial activity of CXCL14 suggests an immediate role in skin infections J Immunol 182 2009 507 514
64. D. Kawashima, N. Oshitani, Y. Jinno, K. Watanabe, S. Nakamura, and K. Higuchi et al. Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease J Clin Pathol 58 2005 1057 1063
65. K.A. Papadakis, J. Prehn, S.T. Moreno, L. Cheng, E.A. Kouroumalis, and R. Deem et al. CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic crohn's disease Gastroenterology 121 2001 246 254
66. H. Ogawa, M. Iimura, L. Eckmann, and M.F. Kagnoff Regulated production of the chemokine CCL28 in human colon epithelium Am J Physiol 287 2004 G1062 G1069
67. P. Middel, D. Raddatz, B. Gunawan, F. Haller, and H. Radzun Increased number of mature dendritic cells in crohn's disease: evidence for a chemokine mediated retention mechanism Gut 55 2006 220 227
68. M. Saruta, Q.T. Yu, A. Avanesyan, P.R. Fleshner, S.R. Targan, and K.A. Papadakis Phenotype and effector function of CC chemokine receptor 9-expressing lymphocytes in small intestinal crohn's disease J Immunol 178 2007 3293 3300
69. T. Mabuchi, T.P. Singh, T. Takekoshi, G.F. Jia, X. Wu, and M.C. Kao et al. CCR6 is required for epidermal trafficking of gammadelta-T cells in an IL-23-induced model of psoriasiform dermatitis J Invest Dermatol 133 2013 164 171
70. B. Homey, H. Alenius, A. Muller, H. Soto, E.P. Bowman, and W. Yuan et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation Nat Med 8 2002 157 165
71. J.B. Rottman, T.L. Smith, K.G. Ganley, T. Kikuchi, and J.G. Krueger Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris Lab Invest 81 2001 335 347
72. B. Homey, M. Dieu-Nosjean, A. Wiesenborn, C. Massacrier, J. Pin, and E. Oldham et al. Up-regulation of macrophage inflammatory protein-3α/CCL20 and CC chemokine receptor 6 in psoriasis J Immunol 164 2000 6621 6632
73. A. Pivarcsi, and B. Homey Chemokine networks in atopic dermatitis: traffic signals of disease Curr Allergy Asthma Rep 5 2005 284 290
74. T.L. Sørensen, M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, and V.A. Folcik et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients J Clin Invest 103 1999 807 815
75. D.J. Mahad, C. Trebst, P. Kivisäkk, S.M. Staugaitis, B. Tucky, and T. Wei et al. Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions J Neuropathol Exp Neurol 63 2004 262 273
76. N.A. Nelken, S.R. Coughlin, D. Gordon, and J.N. Wilcox Monocyte chemoattractant protein-1 in human atheromatous plaques J Clin Invest 88 1991 1121 1127
77. C. Trebst, T. Lykke Sørensen, P. Kivisäkk, M.K. Cathcart, J. Hesselgesser, and R. Horuk et al. CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis Am J Pathol 159 2001 1701 1710
78. J. Barlic, and P.M. Murphy Chemokine regulation of atherosclerosis J Leukoc Biol 82 2007 226 236
79. S. Cardona, J. Garcia, and A. Cardona The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis Methods Mol Biol 1013 2013 1 16
80. A. Müller, B. Homey, H. Soto, N. Ge, D. Catron, and M.E. Buchanan et al. Involvement of chemokine receptors in breast cancer metastasis Nature 410 2001 50 56
81. A. Zlotnik Involvement of chemokine receptors in organ-specific metastasis Contrib Microbiol 13 2006 191 199
82. V. Mirisola, A. Zuccarino, B.E. Bachmeier, M.P. Sormani, J. Falter, and A. Nerlich et al. CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival Eur J Cancer 45 2009 2579 2587
83. C.C. Schimanski, S. Schwald, N. Simiantonaki, C. Jayasinghe, U. Gönner, and V. Wilsberg et al. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer Clin Cancer Res 11 2005 1743 1750
84. F. Andre, W. Xia, R. Conforti, Y. Wei, T. Boulet, and G. Tomasic et al. CXCR4 expression in early breast cancer and risk of distant recurrence Oncologist 14 2009 1182 1188
85. S. Hassan, C. Ferrario, U. Saragovi, L. Quenneville, L. Gaboury, and A. Baccarelli et al. The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer Am J Pathol 175 2009 66 73
86. E. Ramos, A. Camargo, K. Braun, R. Slowik, I. Cavalli, and E. Ribeiro et al. Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer BMC Cancer 10 2010 23
87. E. Razis, K.T. Kalogeras, V. Kotoula, A.G. Eleftheraki, N. Nikitas, and R. Kronenwett et al. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression Clin Breast Cancer 12 2012 183 193
88. Roy I, Zimmerman NP, Mackinnon AC, Tsai S, Evans DB, and Dwinnell MB. 2014 CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. PLoSOne. 9(3): e90400. Epub. 2014 Mar 4; doi: 10.1371/pone.0090400.
89. T. Takekoshi, J.J. Ziarek, B.F. Volkman, and S.T. Hwang A locked, dimeric CXCL12 variant effectively inhibits pulmonary metastasis of CXCR4-expressing melanoma cells due to enhanced serum stability Mol Cancer Ther 11 2012 2516 2525
90. S. Hojo, K. Koizumi, K. Tsuneyama, Y. Arita, Z. Cui, and K. Shinohara et al. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer Cancer Res 67 2007 4725 4731
91. P. Gutwein, A. Schramme, N. Sinke, M.S. Abdel-Bakky, B. Voss, and N. Obermüller et al. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients Eur J Cancer 45 2009 478 489
92. S. Matsumura, B. Wang, N. Kawashima, S. Braunstein, M. Badura, and T.O. Cameron et al. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells J Immunol 181 2008 3099 3107
93. P. Ghadjar, C. Rubie, D.M. Aebersold, and U. Keilholz The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer Int J Cancer 125 2009 741 745
94. E.J. Whalen, S. Rajagopal, and R.J. Lefkowitz Therapeutic potential of β-arrestin- and G protein-biased agonists Trends Mol Med 17 2011 126 139
95. G.A. Donzella, D. Schols, S.W. Lin, J.A. Este, K.A. Nagashima, and P.J. Maddon et al. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor Nat Med 4 1998 72 77
96. C.W. Hendrix, A.C. Collier, M.M. Lederman, D. Schols, R.B. Pollard, and S. Brown et al. Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection J Acquir Immune Defic Syndr 37 2004 1253 1262
97. C.W. Hendrix, C. Flexner, R.T. MacFarland, C. Giandomenico, E.J. Fuchs, and E. Redpath et al. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers Antimicrob Agents Chemother 44 2000 1667 1673
98. Plerixafor: AMD 3100, AMD3100, JM 3100, SDZ SID 791 Drugs R D 8 2007 113 119
99. R. Horuk Chemokine receptor antagonists: overcoming developmental hurdles Nat Rev Drug Discov 8 2009 23 33
100. S. Abel, D.J. Back, and M. Vourvahis Maraviroc: pharmacokinetics and drug interactions Antivir Ther 14 2009 607 618
101. P. Rutgeerts, S. Vermeire, and G. Van Assche Biological therapies for inflammatory bowel diseases Gastroenterology 136 2009 1182 1197
102. M. Yellin, I. Paliienko, A. Balanescu, S. Ter-Vartanian, V. Tseluyko, and L. Xu et al. A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis Arthritis Rheum 64 2012 1730 1739
103. J. Galzi, M. Hachet-Haas, D. Bonnet, F. Daubeuf, S. Lecat, and M. Hibert et al. Neutralizing endogenous chemokines with small molecules: principles and potential therapeutic applications Pharmacol Ther 126 2010 39 55
104. F. Daubeuf, M. Hachet-Haas, P. Gizzi, V. Gasparik, D. Bonnet, and V. Utard et al. An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in mice J Biol Chem 288 2013 11865 11876
105. C.T. Veldkamp, C. Seibert, F.C. Peterson, N.B. De la Cruz, J.C. Haugner III, and H. Basnet et al. Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12 Sci Signal 1 2008 ra4
106. O. Igoucheva, M. Grazzini, A. Pidich, D.M. Kemp, M. Larijani, and M. Farber et al. Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine Gene Ther 20 2013 939 948
107. E. Mohit, A. Bolhassani, F. Zahedifard, N. Seyed, A. Eslamifar, and M. Taghikhani et al. Immunomodulatory effects of IP-10 chemokine along with PEI600-tat delivery system in DNA vaccination against HPV infections Mol Immunol 53 2013 149 160
108. S. Sundararaman, T.J. Miller, J.M. Pastore, M. Kiedrowski, R. Aras, and M.S. Penn Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure Gene Ther 18 2011 867 873
109. T.J. LaRocca, D. Jeong, E. Kohlbrenner, A. Lee, J. Chen, and R.J. Hajjar et al. CXCR4 gene transfer prevents pressure overload induced heart failure J Mol Cell Cardiol 53 2012 223 232
110. M.S. Penn, F.O. Mendelsohn, G.L. Schaer, W. Sherman, M. Farr, and J. Pastore et al. An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure Circ Res 112 2013 816 825
111. J.J. Ziarek, C.T. Veldkamp, F. Zhang, N.J. Murray, G.A. Kartz, and X. Liang et al. Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus J Biol Chem 288 2013 737 746
112. J.H.Y. Tan, J.P. Ludeman, J. Wedderburn, M. Canals, P. Hall, and S.J. Butler et al. Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1) J Biol Chem 288 2013 10024 10034
113. G. Simmons, P.R. Clapham, L. Picard, R.E. Offord, M.M. Rosenkilde, and T.W. Schwartz et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist Science 276 1997 276 279
114. A.E.I. Proudfoot, C.A. Power, A.J. Hoogewerf, M.O. Montjovent, F. Borlat, and R.E. Offord et al. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist J Biol Chem 271 1996 2599 2603
115. T. Kakinuma, and S.T. Hwang Chemokines, chemokine receptors, and cancer metastasis J Leukoc Biol 79 2006 639 651
116. G. Fonseca-Camarillo, and J.K. Yamamoto-Furusho High gene expression of CXCL8 is associated with the presence of extraintestinal manifestations and long-term disease in patients with ulcerative colitis Inflamm Bowel Dis 19 2013 E22 E23